Company ProfilePremium

China National Chemical Corporation (ChemChina)

Company Profile Analysis

中国化工集团有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
China National Chemical Corporation (ChemChina) - Company showcase

Year Founded & Workforce

2004

220,000 Employees

China National Chemical Corporation (ChemChina) logo

China National Chemical Corporation (ChemChina) Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

China National Chemical Corporation (ChemChina) Overview

ChemChina was China's largest chemical manufacturer by breadth and its most aggressive outbound acquirer. Under founder Ren Jianxin it assembled more than a hundred struggling state chemical plants, then bought Western technology leaders: Adisseo, Elkem, Adama, Pirelli, KraussMaffei and, in 2017, Syngenta for US$43 billion, still the largest foreign acquisition by a Chinese company. The strategy delivered global scale in agrochemicals, silicones, animal nutrition and premium tyres, but left a heavily indebted balance sheet. In 2021 Beijing folded ChemChina into Sinochem Holdings, described at formation as the world's largest chemical conglomerate. Today ChemChina is best understood as a legal holding layer inside Sinochem. Its economic value sits in Syngenta Group, Bluestar and a shrinking Pirelli stake, and its strategic direction is set by the parent and by SASAC.

Three-year employee trend. No standalone ChemChina headcount has been published for 2023 to 2025. The only available trend is at parent level: roughly 220,000 in 2021 falling to 203,727 by the 2024 Fortune list.


The company's own description. ChemChina published no annual report in the Western sense. The closest current self-description is the parent's. Sinochem Holdings describes itself as formed through the restructuring of Sinochem Group and ChemChina, operating in eight sectors: life science, materials science, basic chemicals, environmental science, rubber and tyre, machinery and equipment, city operation and industrial finance. It claims leadership in agrochemicals and animal nutrition, in fluorine and silicon materials, engineering plastics and rubber additives, in high-end tyres, and in plastics machinery (Sinochem Holdings corporate profile).

Before the merger ChemChina described itself through six business sectors: new chemical materials and specialty chemicals, basic chemicals, oil processing, agrochemicals, tyre and rubber products, and chemical equipment, supported by a network of research and design institutes inherited from the former Ministry of Chemical Industry.

Independent characterisation. ChemChina is a state holding company, not an integrated operating company. Its business model has three layers.

First, it holds controlling stakes in operating platforms, several separately listed: Syngenta Group (unlisted), ADAMA Ltd. (Shenzhen), Bluestar Adisseo (Shanghai), Elkem ASA (Oslo), Haohua Chemical Science & Technology (Shanghai), Aeolus Tyre (Shanghai), KraussMaffei Co. Ltd. (Shanghai) and others.

Second, revenue is almost entirely product sales. Licensing income exists inside Syngenta (seed traits) and is not broken out at group level. There is no subscription model of note, although Syngenta's CROPWISE digital platform and the MAP (Modern Agriculture Platform) service centres in China add a service layer.

Third, value chain position varies by platform. Syngenta and Adama sit at the innovation and formulation end of crop inputs. Elkem and Bluestar Silicones are integrated from quartz and silicon metal to silicone specialities. Adisseo makes methionine and feed additives. The oil processing arm, built on a group of independent refineries mostly in Shandong, is a commodity processor. Pirelli is a pure consumer tyre maker focused on high-value tyres.

Customers and end-markets. Customers include farmers and agricultural distributors (the largest end-market by revenue), feed compounders and integrated livestock producers, car makers and tyre dealers, plastics processors, construction, electronics and solar value chains for silicon materials, and domestic fuel and petrochemical buyers for refinery output.

Strategy

Stated strategy. At formation, Sinochem Holdings said it would benchmark itself against international peers and aim to become a global player on size, technology, innovation capability and industrial chain (Yicai). The legacy Sinochem slogan "In Science We Trust" was carried into the merged group.

Initiatives in the last 24 months.

Quality over volume at Syngenta: The group cut about US$1 billion of low-margin grain trading sales in 2025, restructured MAP, and spun Sinofert out to Sinochem Hong Kong. Management describes H1 2026 as a deliberate shift toward higher-quality earnings instead of sales growth.

Artificial intelligence: Syngenta prioritised AI in 2025 through "lighthouse" projects and in 2026 integrated AI into CROPWISE and invested in external partnerships.

Biologicals: Double-digit growth in 2025; a declared priority platform.

Pirelli stake reduction: After two Italian government interventions, Sinochem sold 14% in July 2026. Italy's restrictions apply as long as it holds more than 9.99%, which creates a clear incentive toward further sell-down. Sinochem reportedly appointed BNP Paribas to advise on a sale (Reuters via MarketScreener).

Syngenta listing: After withdrawing the Shanghai application in March 2024, press reports now point to a Hong Kong IPO not before 2027 (AgFeed, August 2026). Unconfirmed by the company in sources reviewed.

Financial targets. Neither ChemChina nor Sinochem Holdings publishes medium-term guidance. Syngenta Group gives no numerical outlook in the releases reviewed.

Products & Services

Agrochemicals: Syngenta Crop Protection. The unit sells herbicides, fungicides, insecticides, seed treatments and biologicals to farmers worldwide. Syngenta's H1 2026 commentary singles out three technology brands as growth drivers. PLINAZOLIN technology is a novel-mode-of-action insecticide active ingredient (isocycloseram). ADEPIDYN technology is a broad-spectrum SDHI fungicide (pydiflumetofen) sold under brands such as Miravis. TYMIRIUM technology is a nematicide and fungicide (cyclobutrifluram) for seed and soil application. Established franchises include Amistar (azoxystrobin), Elatus (benzovindiflupyr), Callisto (mesotrione), Acuron, Axial, Cruiser and Vibrance seed treatments, and Gramoxone (paraquat, sold outside jurisdictions that ban it). The biologicals business, which includes Valagro (acquired 2020), recorded double-digit sales growth in 2025.

Agrochemicals: Syngenta Seeds. Field crops (corn, soybean, sunflower, cereals) are sold under brands including NK and Golden Harvest in the Americas. Vegetable seeds are sold under the Syngenta Vegetable Seeds name, and flowers under Syngenta Flowers. Trait licensing forms part of the revenue model. Brazil is the strongest growth market, with field crop seed sales up 17% in 2025 and 18% in H1 2026.

Agrochemicals: ADAMA. Adama is an off-patent (post-patent) crop protection formulator and active ingredient producer with a large differentiated-formulation portfolio, based in Israel and listed in Shenzhen. FY2025 sales were US$4.1 billion.

Agrochemicals: Syngenta Group China. This unit combines crop protection, seeds, crop nutrition and the MAP network of farm service centres plus digital agriculture. Following the Sinofert transfer in December 2025, the fertiliser business is no longer consolidated.

Digital. CROPWISE is Syngenta's digital agronomy platform; AI capabilities were integrated into it during 2026.

Animal nutrition: Bluestar Adisseo. Products include methionine in liquid (Rhodimet AT88) and powder (Rhodimet NP99) forms, vitamins (Microvit), rumen-protected methionine (Smartamine, MetaSmart), feed enzymes (Rovabio), and specialities for mycotoxin management, palatability and aquaculture. Adisseo is one of the world's largest methionine producers, with plants in France, Spain and Nanjing.

Silicon materials: Elkem and Bluestar Silicones. Elkem's product families are silicon metal and ferrosilicon, foundry alloys, carbon products (electrode paste, Søderberg materials), Microsilica, and silicones (elastomers, release coatings, fluids, sealant polymers) made in France and at Xinghuo in Jiangxi.

Specialty and fluorine materials: Haohua Chemical Science & Technology. The portfolio covers fluoropolymers (PTFE, fluoro-rubber), electronic specialty gases, aerospace chemical materials, coatings and engineering services, built on former ministry research institutes.

Basic chemicals. Products include paste PVC resin and chlor-alkali (Shenyang Chemical), TDI and polycarbonate (Cangzhou Dahua), and other commodity intermediates.

Oil processing. A group of independent refineries produces transport fuels and petrochemical feedstocks. Capacities are not publicly disclosed in sources reviewed.

Tyres. Pirelli makes premium and prestige car and motorcycle tyres: P Zero, Cinturato, Scorpion, Diablo (motorcycle) and Cyber Tyre sensor-equipped connected tyres. Cyber Tyre is the technology at the centre of the Italian and US regulatory concerns. Aeolus Tyre makes truck, bus and off-the-road tyres in China. Prometeon Tyre Group makes Pirelli-branded industrial tyres under licence.

Machinery: KraussMaffei. Product lines are injection moulding machines, extrusion lines (the former KraussMaffei Berstorff) and reaction process machinery, plus Chinese chemical and rubber machinery units.

Launch years, pricing models and specifications for individual products are disclosed only in subsidiary product literature and were not compiled.

Financial Narrative

Disclosure position. A full five-year income statement, balance sheet and cash flow for ChemChina cannot be assembled from accessible public sources. The company's last standalone appearance in the Fortune Global 500 was the 2020 list (rank 164 on FY2019 revenue, per Yicai and Team France Export summaries). EPS, dividends per share and buybacks are not applicable. Gross profit, operating income, EBITDA, debt split, goodwill, working capital, cash flows and all ratios at ChemChina level are not publicly disclosed in sources reviewed.

Treat them as indicative.

Table 6.2 Sinochem Holdings (parent), post-merger. FY2021 from Fortune's 2022 newcomer feature (rank 31, US$172 billion). FY2023 from the Fortune company profile (updated August 2024).

Table 6.3 Syngenta Group five-year record. FY2025 and FY2024 from the 30 March 2026 release.

Sales CAGR FY2021 to FY2025 is about 0.2% a year. Syngenta Group's net income, debt, cash flow and capex are disclosed in its bond-market financial reports but were not captured here.

Table 6.4 Syngenta Group H1 2026 (release of 27 August 2026; prior-year figures restated for the Sinofert transfer).

Commentary.

Revenue: ChemChina's revenue growth from FY2016 to FY2018 was acquisition-driven: Syngenta was consolidated from mid-2017. The FY2019 dip reflected weak commodity chemical and refining prices. After the merger, parent revenue fell sharply in FY2023, in step with lower oil and chemical prices and agrochemical channel destocking.

Profitability: The parent recorded a US$3.7 billion loss for FY2023. ChemChina itself reported attributable net losses in several pre-merger years according to press and rating agency commentary, driven by interest on acquisition debt and weak commodity units.

Syngenta inflection: Syngenta's EBITDA peaked in FY2022 at US$5.6 billion on exceptional crop prices, fell for two years through the industry destocking cycle, and recovered 13% in FY2025 with a 1.9-point margin gain. H1 2026 margin of 19.5% extends the recovery. Management attributes it to portfolio mix, cost discipline and the exit from low-margin trading.

Leverage: The Syngenta purchase was financed almost entirely with debt and perpetual instruments.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Chemchina Sector Details

ChemChina sector (pre-2021)Main operating platformsPrincipal productsCurrent home inside Sinochem Holdings

New chemical materials and specialty chemicals

China National Bluestar (Elkem, Bluestar Adisseo, Bluestar Silicones), Haohua Chemical Science & Technology

Silicon metal, silicones, methionine, vitamins, fluorine materials, specialty gases, engineering plastics

Materials science; life science (animal nutrition)

Basic chemicals

China Haohua, Shenyang Chemical, Cangzhou Dahua and others

Chlor-alkali, PVC paste resin, TDI, polycarbonate, fertiliser intermediates

Basic chemicals

Oil processing

ChemChina Petrochemical (independent refineries, mainly Shandong)

Gasoline, diesel, propylene, petrochemical feedstocks

Basic chemicals / energy

Agrochemicals

Syngenta Group (Syngenta Crop Protection, Syngenta Seeds, ADAMA, Syngenta Group China)

Crop protection, seeds, biologicals, digital and farm services

Life science

Tyre and rubber

China National Tire & Rubber Corp. (CNRC): Pirelli stake, Aeolus Tyre, Prometeon

Car, motorcycle, truck and off-road tyres

Rubber and tyre

Chemical equipment

China National Chemical Equipment: KraussMaffei

Injection moulding, extrusion and reaction process machinery; chemical and rubber machinery

Machinery and equipment

Syngenta Group sales by business unit (USD Bn)

Syngenta Group sales by business unit (USD Bn)FY2023FY2024FY2025

Group sales (USD Bn)

32.228.828.4

Syngenta Crop Protection (USD Bn)

15.513.213.7

Syngenta Seeds (USD Bn)

4.84.74.8

ADAMA (USD Bn)

4.64.24.1

Syngenta Group China (USD Bn)

9.79.28.3

Group EBITDA (USD Bn)

4.63.94.4

Group EBITDA margin (%)

14.213.515.4

Syngenta Group FY2025 Details

Syngenta Group FY2025Sales (USD Bn)YoY growthShare of unit total

Syngenta Crop Protection

13.7

+4% (+3% CER)

44%

Syngenta Seeds

4.8

+2% (+2% CER)

16%

ADAMA

4.1-2%13%

Syngenta Group China

8.3

-10% (-9% CER)

27%

Financial Analysis

MetricFY2016FY2017FY2018FY2019
—45,17757,98967,39865,767

Fortune Global 500 rank (list of following year)

211167144164

Income Statement

MetricFY2021FY2022FY2023

Revenue (USD Mn)

172,000173,800143,240

Net income (USD Mn)

——-3,666

Fortune Global 500 rank (list of following year)

313854

Employees

——203,727

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Sales (USD Bn)

28.233.432.228.828.4

EBITDA (USD Bn)

4.65.64.63.94.4

EBITDA margin (%)

16.316.814.213.515.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%) (Half-Yearly)

MetricH1 2025H1 2026

Group sales (USD Bn)

12.512.2

Group EBITDA (USD Bn)

2.32.4

EBITDA margin (%)

18.619.5

Syngenta Crop Protection sales (USD Bn)

—6.6

Syngenta Seeds sales (USD Bn)

—2.5

ADAMA sales (USD Bn)

—2.1

Syngenta Group China sales (USD Bn)

2.92.5

Revenue by Region and Region Margins & Growth (%)

MetricFY2023FY2024FY2025

Syngenta Group China sales (USD Bn)

9.79.28.3

Syngenta Group China growth (%)

—-5-10

Group sales (USD Bn)

32.228.828.4

Peer Comparison

CompanyExchangeTickerGroup interest

ADAMA Ltd.

Shenzhen

000,553

Majority, via Syngenta Group

Bluestar Adisseo

Shanghai

600,299

Majority, via Bluestar

Elkem ASA

Oslo

ELK

—

Haohua Chemical Science & Technology

Shanghai

600,378

Majority

Aeolus Tyre

Shanghai

600,469

Controlling

KraussMaffei Co. Ltd.

Shanghai

600,579—

Shenyang Chemical

Shenzhen

000,698

Controlling

Cangzhou Dahua

Shanghai

600,230

Controlling

Pirelli & C.

Milan

PIRC

20.1% after July 2026

Analyst Conclusions

Guidance and expectations. No guidance exists at ChemChina or Sinochem Holdings level. Syngenta's tone in August 2026 is that margin quality will take priority over sales growth. There is no sell-side consensus.

Bull case.

  1. Syngenta's earnings have turned: EBITDA rose 13% in FY2025 and the H1 2026 margin reached 19.5%, with the destocking cycle over and new actives gaining share.

  2. Portfolio clean-up is real: grain trading cut, Sinofert removed, Pirelli stake monetised. Each step makes the core asset easier to list.

  3. A Hong Kong listing in 2027 under a Chinese CEO has a clearer regulatory path than the abandoned Shanghai attempt and would reset leverage.

Bear case.

  1. Reported sales are still falling (-2% in H1 2026, -7% at constant currency) and China, the home market, is the weakest unit.

  2. Chinese state ownership has become a liability in Western markets. Pirelli shows that governments will strip governance rights; the same logic could reach seeds, farmland or data-rich digital agriculture.

  3. The balance sheet remains opaque and heavily indebted, the parent lost US$3.7 billion in FY2023, and IPO timing has slipped repeatedly since 2021.

Catalysts and monitorables, next 12 months.

  • Formal Syngenta Group listing application in Hong Kong and its disclosed leverage.

  • Any further Pirelli sale taking the stake below 9.99%.

  • Syngenta FY2026 results (expected late March 2027) and Brazil credit quality.

  • Elkem silicones restructuring outcome.

  • Sinochem Holdings' 2027 Fortune Global 500 figures and onshore bond annual report.

  • US policy on Chinese-owned agricultural and connected-vehicle businesses.

  • First strategic statements from Hengde Qin.

Analyst verdict. ChemChina no longer exists as an independent strategic actor, and it should not be analysed as one. It is a legal shell inside Sinochem Holdings holding the proceeds of a fifteen-year acquisition campaign that bought world-class assets with borrowed money. The verdict on that campaign is mixed. Syngenta, ADAMA, Adisseo and Elkem gave China technology, brands and market positions it could not have built in the time available, and Syngenta Group is now the largest agricultural inputs company in the world with margins that are finally recovering. Against that, the group paid full prices, carried the debt through a commodity downturn and a failed IPO, and its parent was loss-making in FY2023. The Pirelli episode is the more important signal for the future. In 2015 a Chinese state buyer was welcomed in Milan; by 2026 the Italian state had twice overridden its rights and it sold down at the first credible bid. That change in the political climate caps what the group can own abroad and raises the discount on what it already holds. The investment question therefore narrows to one asset and one event: whether Syngenta can list in Hong Kong in 2027 on the back of two years of margin improvement, and at a valuation that meaningfully reduces debt. If it does, the ChemChina legacy will look like an expensive but successful technology acquisition. If the listing slips again, the group remains what it has been since 2017, a strong agricultural business carrying a weak balance sheet, dependent on state banks and state patience.


Sources consulted for verification (October 2026): Syngenta Group FY2025 results release (30 to 31 March 2026) and H1 2026 release (27 August 2026); Syngenta Group board of directors page; Fortune company profile for Sinochem Holdings and Fortune's 2022 Global 500 newcomers feature; Yicai Global (10 May 2021); Team France Export note citing Sina and China Daily (May 2021); Sinochem Holdings corporate profile; Just Auto (31 July 2026); Il Post (11 April 2026); Il Sole 24 Ore; Reuters reports via MarketScreener, SA Treads and CB Insights; AgFeed, Fertilizer Daily, Indian Chemical News and Bluewin coverage of Syngenta results.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleTenure and backgroundCompensation

Li Fanrong

Chairman, Sinochem Holdings; Chairman, Syngenta Group

Chairman since August 2022; previously President of Sinochem Holdings, CEO of CNOOC Ltd., Deputy Director General of the National Energy Administration, President of CNPC and Vice Chairman of PetroChina. Petroleum engineering graduate of Jianghan Petroleum Institute; MBA, Cardiff University (Syngenta Group board biography).

—

Ning Gaoning (Frank Ning)

Former Chairman, ChemChina (2018 to 2021) and Sinochem Holdings (2021 to 2022)

Previously chairman of Sinochem Group, COFCO and China Resources. Architect of the merger. Retired 2022.

—

Ren Jianxin

Founder; General Manager 2004 to 2014; Chairman 2014 to 2018

Founded Bluestar in 1984; led every major overseas acquisition. Retired June 2018.

—

Hengde Qin

CEO, Syngenta Group

From 1 August 2026; first Chinese national in the role.

—

Jeff Rowe

Former CEO, Syngenta Group

January 2024 to July 2026; left to become COO and Executive Vice President of ADM (AgFeed).

—

Erik Fyrwald

Former CEO, Syngenta (2016 to 2023)

Led Syngenta through the acquisition and the formation of Syngenta Group.

—

Nelson Jiang

CFO, Syngenta Group

Effective 1 March 2026 (FY2025 release).

—

Marco Tronchetti Provera

Executive Vice Chairman, Pirelli; controls Camfin

Long-standing Pirelli leader; counterparty to Sinochem in the governance dispute.

See Pirelli remuneration report

Andrea Casaluci

CEO, Pirelli

—

See Pirelli remuneration report

“—” = not publicly disclosed.

Competitive Landscape

Competitors by Segment

SegmentNamed competitorsPositioning of ChemChina platform

Crop protection

Bayer Crop Science, BASF Agricultural Solutions, Corteva, FMC, UPL, Sumitomo Chemical, Nufarm

Syngenta Group describes itself as the world's largest agricultural technology company by revenue; number one in crop protection with ADAMA included

Seeds

Bayer, Corteva, BASF, KWS, Limagrain

Number three globally

Animal nutrition

Evonik, Novus, CJ CheilJedang, Sumitomo, NHU, DSM-Firmenich

Adisseo among the top methionine producers

Silicones and silicon

Dow, Wacker, Shin-Etsu, Momentive, Hoshine, Ferroglobe

Elkem integrated but exposed to Chinese overcapacity

Premium tyres

Michelin, Bridgestone, Continental, Goodyear

Pirelli a focused high-value niche leader

Plastics machinery

Engel, Arburg, Haitian International, Milacron

KraussMaffei strong in technology, weak in profitability

Diversified chemicals (group level)

Sinopec, BASF, Dow, Wanhua Chemical, Rongsheng, Hengli

Parent described at formation as largest by revenue

Peer Comparison FY2025

Company (agricultural business, FY2025)Sales (USD Bn)Sales growthEBITDA margin

Syngenta Group

28.4-1%15.4%

Recent Developments

Seventeen could be dated with confidence.

Company Snapshot

$143,240M

Revenue

220,000

Employees

2004

Founded

SWOT Analysis

Strengths

  • Largest agricultural inputs business globally: Syngenta Group sales of US$28.4 billion in FY2025.
  • Improving profitability: Syngenta EBITDA up 13% in FY2025 and margin at 19.5% in H1 2026, with margin gains in all four units.
  • Innovation pipeline with named new actives (PLINAZOLIN, ADEPIDYN, TYMIRIUM) driving Crop Protection growth of 4% in both FY2025 and H1 2026.
  • Regulatory productivity: almost 900 registrations and label extensions in H1 2026.
  • Sovereign backing: wholly owned through Sinochem Holdings by SASAC, with 16 listed affiliates across the merged group at formation.
  • Global reach: operations in more than 150 countries and regions, with over 90,000 overseas staff in the combined group in 2021.

Weaknesses

  • Parent-level losses: Sinochem Holdings lost US$3.7 billion in FY2023 on revenue of US$143.2 billion.
  • Debt legacy of the US$43 billion Syngenta purchase, which was funded with borrowings.
  • Failed equity raise: the RMB 65 billion Shanghai IPO was withdrawn in March 2024 after nearly three years.
  • Shrinking China agriculture unit: Syngenta Group China sales down 10% in FY2025 and 15% in H1 2026.

Opportunities

  • A Hong Kong listing of Syngenta, reported for 2027, would crystallise value and cut debt.
  • Biologicals, growing at double-digit rates in 2025.
  • Brazil: seed sales up 17% to 18% and crop protection up 7%.
  • AI in discovery and agronomy, with CROPWISE integration in 2026.
  • Proceeds from Pirelli: the 14% sale in July 2026 releases cash, and a further 10 points could follow.
  • China food security policy, which favours a national champion in seeds and biotechnology.

Threats

  • Host-government intervention: Italy used golden power in 2023 and again in April 2026 against Sinochem.
  • US restrictions: Pirelli and Camfin state that Chinese ownership impedes US expansion in connected vehicle technology; ChemChina was named on a US Department of Defense list in 2020.
  • Brazilian customer credit risk, which required higher provisions in Q4 2025.
  • Pricing pressure in off-patent crop protection: ADAMA sales flat in H1 2026 despite volume growth.
  • US acreage volatility: North America seed sales down 13% in H1 2026.
  • Paraquat and other product liability litigation in the United States.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
April 2025Pirelli board, approving FY2024 accounts, determines Sinochem no longer controls the companyFormal loss of control; opens the governance dispute
Mid 2025Reuters reports Sinochem could consider selling its Pirelli stake if a premium offer emergedFirst signal of exit
August 2025Syngenta Group H1 2025: sales US$12.5 billion and EBITDA US$2.3 billion on the restated basisRecovery under way
23 December 2025Syngenta transfers its Sinofert stake to Sinochem Hong KongPerimeter simplification before a listing
30 January 2026Camfin announces it will not renew the Pirelli shareholder pactTriggers a new golden power review
Early February 2026Sinochem proposes a "structured solution" on Pirelli governance; Camfin rejects it as harmful to Pirelli's modelDispute hardens
1 March 2026Nelson Jiang becomes Syngenta Group CFOFinance leadership change ahead of IPO
March 2026Pirelli postpones its board meeting on FY2025 accounts to 16 April pending the golden power outcomeGovernance paralysis
30 to 31 March 2026Syngenta FY2025: sales US$28.4 billion (-1%), EBITDA US$4.4 billion (+13%), margin 15.4%Margin recovery confirmed
About 10 April 2026Italy exercises golden power: Sinochem limited to three Pirelli directors, two independentSinochem loses board influence
16 April 2026Pirelli board approves FY2025 draft accountsNormal reporting resumes
May 2026Pirelli shareholder pact expiresEnd of the 2015 partnership structure
3 July 2026Press reports Czech investors seek 10% to 20% of Pirelli from SinochemBuyer emerges
Late July 2026Sinochem sells 14% of Pirelli to Lumina Crown; stake falls to 20.1%Largest divestiture by the group since the merger
1 August 2026Hengde Qin succeeds Jeff Rowe as Syngenta Group CEOChinese leadership of the core asset
27 August 2026Syngenta H1 2026: sales US$12.2 billion (-2%, -7% CER), EBITDA US$2.4 billion (+2%), margin 19.5%Margins up in every unit
August 2026Press reports Syngenta Hong Kong IPO now targeted for 2027Unconfirmed; key capital event

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

3 charts
Syngenta Group Sales by Business Unit: Group sales fell from USD 32,200 Mn in FY2023 to USD 28,400 Mn in FY2025.
China National Chemical Corporation (ChemChina) — Syngenta Group Sales by Business Unit
Series (USD Mn)FY2023FY2024FY2025
Group sales32,20028,80028,400
Syngenta Crop Protection15,50013,20013,700
Syngenta Seeds4,8004,7004,800
ADAMA4,6004,2004,100
Syngenta Group China9,7009,2008,300
Group EBITDA4,6003,9004,400

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.